{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T21:05:10Z","timestamp":1789506310240,"version":"build-2803163510"},"reference-count":76,"publisher":"American Chemical Society (ACS)","issue":"36","license":[{"start":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:00Z","timestamp":1788307200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Funda??o de Amparo ? i Pesquisa do Estado de S?o Paulo","doi-asserted-by":"publisher","award":["2018\/14818-9"],"award-info":[{"award-number":["2018\/14818-9"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda??o de Amparo ? i Pesquisa do Estado de S?o Paulo","doi-asserted-by":"publisher","award":["2018\/15038-7"],"award-info":[{"award-number":["2018\/15038-7"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda??o de Amparo ? i Pesquisa do Estado de S?o Paulo","doi-asserted-by":"publisher","award":["2019\/02821-8"],"award-info":[{"award-number":["2019\/02821-8"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda??o de Amparo ? i Pesquisa do Estado de S?o Paulo","doi-asserted-by":"publisher","award":["2019\/13692-4"],"award-info":[{"award-number":["2019\/13692-4"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda??o de Amparo ? i Pesquisa do Estado de S?o Paulo","doi-asserted-by":"publisher","award":["2019\/15619-2"],"award-info":[{"award-number":["2019\/15619-2"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda??o de Amparo ? i Pesquisa do Estado de S?o Paulo","doi-asserted-by":"publisher","award":["2019\/266862"],"award-info":[{"award-number":["2019\/266862"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda??o de Amparo ? i Pesquisa do Estado de S?o Paulo","doi-asserted-by":"publisher","award":["2020\/08271-7"],"award-info":[{"award-number":["2020\/08271-7"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda??o de Amparo ? i Pesquisa do Estado de S?o Paulo","doi-asserted-by":"publisher","award":["2020\/08840-1"],"award-info":[{"award-number":["2020\/08840-1"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda??o de Amparo ? i Pesquisa do Estado de S?o Paulo","doi-asserted-by":"publisher","award":["2021\/03418-2"],"award-info":[{"award-number":["2021\/03418-2"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda??o de Amparo ? i Pesquisa do Estado de S?o Paulo","doi-asserted-by":"publisher","award":["2023\/01291-0"],"award-info":[{"award-number":["2023\/01291-0"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda??o de Amparo ? i Pesquisa do Estado de S?o Paulo","doi-asserted-by":"publisher","award":["2023\/02690-6"],"award-info":[{"award-number":["2023\/02690-6"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda??o de Amparo ? i Pesquisa do Estado de S?o Paulo","doi-asserted-by":"publisher","award":["2023\/03195-9"],"award-info":[{"award-number":["2023\/03195-9"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda??o de Amparo ? i Pesquisa do Estado de S?o Paulo","doi-asserted-by":"publisher","award":["2023\/07464-4"],"award-info":[{"award-number":["2023\/07464-4"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda??o de Amparo ? i Pesquisa do Estado de S?o Paulo","doi-asserted-by":"publisher","award":["2023\/12447-1"],"award-info":[{"award-number":["2023\/12447-1"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda??o de Amparo ? i Pesquisa do Estado de S?o Paulo","doi-asserted-by":"publisher","award":["2024\/02802-1"],"award-info":[{"award-number":["2024\/02802-1"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda??o de Amparo ? i Pesquisa do Estado de S?o Paulo","doi-asserted-by":"publisher","award":["25\/10094-0"],"award-info":[{"award-number":["25\/10094-0"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena??o de Aperfei?oamento de Pessoal de N?vel Superior","doi-asserted-by":"publisher","award":["001"],"award-info":[{"award-number":["001"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena??o de Aperfei?oamento de Pessoal de N?vel Superior","doi-asserted-by":"publisher","award":["88881.127024\/2025-01"],"award-info":[{"award-number":["88881.127024\/2025-01"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena??o de Aperfei?oamento de Pessoal de N?vel Superior","doi-asserted-by":"publisher","award":["88887.900292\/2023-00"],"award-info":[{"award-number":["88887.900292\/2023-00"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena??o de Aperfei?oamento de Pessoal de N?vel Superior","doi-asserted-by":"publisher","award":["88887.951013\/2024-00"],"award-info":[{"award-number":["88887.951013\/2024-00"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient?fico e Tecnol?gico","doi-asserted-by":"publisher","award":["303869\/2021-6"],"award-info":[{"award-number":["303869\/2021-6"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Development of resistance to taxane-based chemotherapy, specifically docetaxel (DTX), in advanced prostate cancer is frequent. Natural compounds, such as narciclasine, an alkaloid derived from plants, offer a potentially advantageous approach. Docetaxel-resistant prostate cancer cell lines (DU145RST and PC3RST) were established and treated with narciclasine (1) and its derivatives, narciclasine-3,4-acetonide (1a) and 7-deoxynarciclasine (1b), and evaluated for cytotoxicity, cell proliferation, cell cycle progression, clonogenicity, and 3D spheroid growth. In silico target prediction was undertaken employing PharmMapper, and the molecular pathways involved in resistance were confirmed by western blot. The resistant cell lines showed an increase in IC50 values above 6 nM in DU145RST and 4 nM in PC3RST of docetaxel; molecular alterations included increased mTOR and S6 signaling pathways. Narciclasine-based compounds decreased cell viability within both sensitive and resistant lines, interestingly displaying increased potency in the resistant sublines alongside minimal toxicity in nontumorigenic cell types. Cell cycle assessments unraveled G2\/M arrest, particularly in the resistant model, a decline in clonogenic capacity, 3D spheroid fragmentation, and reduced viability. The in silico analysis identified CDK2, alongside cyclin A2, as targets, which certainly bolsters findings of cell cycle abrogation. Reduced concentrations of both CDK2 and cyclin A2 confirm the observed effects. Overall, the tested compounds 1, 1a, and 1b exhibited potent and selective antitumor activity in docetaxel-resistant prostate cancer models by impairing proliferation and inducing cell cycle arrest. Therefore, these compounds represent promising candidates to overcome taxane resistance through modulation of cell cycle regulators such as CDK2 and cyclin A2.<\/jats:p>","DOI":"10.1021\/acsomega.6c05272","type":"journal-article","created":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T18:04:32Z","timestamp":1788458672000},"page":"54245-54265","source":"Crossref","is-referenced-by-count":0,"title":["Overcoming Docetaxel\nResistance in Prostate Cancer\nby Targeting Cell Cycle Progression with Narciclasine-Based Compounds"],"prefix":"10.1021","volume":"11","author":[{"given":"Ranyelison","family":"Silva Machado","sequence":"first","affiliation":[{"name":"Federal University of Sa\u0303o Paulo , , , ,","place":["Sa\u0303o Paulo, Sa\u0303o Paulo, Brazil, 04039-032"]},{"name":"Federal University of Sa\u0303o Paulo , , ,","place":["Diadema, Sa\u0303o Paulo, Brazil, 09972-270"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaio","family":"S. Gomes","sequence":"additional","affiliation":[{"name":"Federal University of ABC , , ,","place":["Santo Andre, Sa\u0303o Paulo, Brazil, 09210-180"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Augusto","family":"B. Farias","sequence":"additional","affiliation":[{"name":"Federal University of ABC , , ,","place":["Santo Andre, Sa\u0303o Paulo, Brazil, 09210-180"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nata\u0301lia","family":"Meneses Arau\u0301jo","sequence":"additional","affiliation":[{"name":"Federal University of Sa\u0303o Paulo , , , ,","place":["Sa\u0303o Paulo, Sa\u0303o Paulo, Brazil, 04039-032"]},{"name":"Federal University of Sa\u0303o Paulo , , ,","place":["Diadema, Sa\u0303o Paulo, Brazil, 09972-270"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Barbosa Chanes","sequence":"additional","affiliation":[{"name":"Federal University of Sa\u0303o Paulo , , , ,","place":["Sa\u0303o Paulo, Sa\u0303o Paulo, Brazil, 04039-032"]},{"name":"Federal University of Sa\u0303o Paulo , , ,","place":["Diadema, Sa\u0303o Paulo, Brazil, 09972-270"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura Maria","family":"Pinto Dias","sequence":"additional","affiliation":[{"name":"Federal University of Sa\u0303o Paulo , , , ,","place":["Sa\u0303o Paulo, Sa\u0303o Paulo, Brazil, 04039-032"]},{"name":"Federal University of Sa\u0303o Paulo , , , ,","place":["Sa\u0303o Paulo, Sa\u0303o Paulo, Brazil, 04044-020"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianca","family":"Zaia Franco Ferreira","sequence":"additional","affiliation":[{"name":"Federal University of Sa\u0303o Paulo , , , ,","place":["Sa\u0303o Paulo, Sa\u0303o Paulo, Brazil, 04044-020"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla Cristina","family":"Lopes","sequence":"additional","affiliation":[{"name":"Federal University of Sa\u0303o Paulo , , , ,","place":["Sa\u0303o Paulo, Sa\u0303o Paulo, Brazil, 04044-020"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ileana G. S.","family":"Rubio","sequence":"additional","affiliation":[{"name":"Federal University of Sa\u0303o Paulo , , , ,","place":["Sa\u0303o Paulo, Sa\u0303o Paulo, Brazil, 04039-032"]},{"name":"Federal University of Sa\u0303o Paulo , , , ,","place":["Diadema, Sa\u0303o Paulo, Brazil, 09972-270"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Moreira Simabuco","sequence":"additional","affiliation":[{"name":"Federal University of Sa\u0303o Paulo , , , ,","place":["Sa\u0303o Paulo, Sa\u0303o Paulo, Brazil, 04044-020"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6586-5107","authenticated-orcid":true,"given":"Daniela","family":"G. G. Rando","sequence":"additional","affiliation":[{"name":"Federal University of Sa\u0303o Paulo , , ,","place":["Diadema, Sa\u0303o Paulo, Brazil, 09972-270"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugo","family":"Pequeno Monteiro","sequence":"additional","affiliation":[{"name":"Federal University of Sa\u0303o Paulo , , , ,","place":["Sa\u0303o Paulo, Sa\u0303o Paulo, Brazil, 04039-032"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adolfo","family":"Garcia Erustes","sequence":"additional","affiliation":[{"name":"Federal University of Sa\u0303o Paulo , , , ,","place":["Sa\u0303o Paulo, Sa\u0303o Paulo, Brazil, 04044-020"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soraya Soubhi","family":"Smaili","sequence":"additional","affiliation":[{"name":"Federal University of Sa\u0303o Paulo , , , ,","place":["Sa\u0303o Paulo, Sa\u0303o Paulo, Brazil, 04044-020"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7094-9826","authenticated-orcid":true,"given":"David","family":"Ryffel","sequence":"additional","affiliation":[{"name":"Rice University , , , ,","place":["Houston, Texas, United States, 770055"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8736-8953","authenticated-orcid":true,"given":"David","family":"Sarlah","sequence":"additional","affiliation":[{"name":"Rice University , , , ,","place":["Houston, Texas, United States, 770055"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8606-5400","authenticated-orcid":true,"given":"Giselle","family":"Cerchiaro","sequence":"additional","affiliation":[{"name":"Federal University of ABC , , ,","place":["Santo Andre, Sa\u0303o Paulo, Brazil, 09210-180"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1193-8374","authenticated-orcid":true,"given":"Joa\u0303o Henrique G.","family":"Lago","sequence":"additional","affiliation":[{"name":"Federal University of ABC , , ,","place":["Santo Andre, Sa\u0303o Paulo, Brazil, 09210-180"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7767-0887","authenticated-orcid":true,"given":"Rodrigo Esaki","family":"Tamura","sequence":"additional","affiliation":[{"name":"Federal University of Sa\u0303o Paulo , , , ,","place":["Sa\u0303o Paulo, Sa\u0303o Paulo, Brazil, 04039-032"]},{"name":"Federal University of Sa\u0303o Paulo , , ,","place":["Diadema, Sa\u0303o Paulo, Brazil, 09972-270"]},{"name":"University of Sa\u0303o Paulo , , , ,","place":["Sa\u0303o Paulo, Sa\u0303o Paulo, Brazil, 05508-000"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2026,9,2]]},"reference":[{"issue":"4","key":"2026091516123863500_cit1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.70090","article-title":"Global cancer statistics 2024: GLOBOCAN estimates\nof incidence and mortality worldwide for 34 cancers in 186 countries","volume":"76","author":"Sung","year":"2026","journal-title":"Ca-Cancer J. Clin."},{"issue":"2","key":"2026091516123863500_cit2","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.eururo.2024.03.027","article-title":"EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on\nprostate cancer\u25002024 update. Part I: Screening, diagnosis,\nand local treatment with curative intent","volume":"86","author":"Cornford","year":"2024","journal-title":"Eur.\nUrol."},{"issue":"2","key":"2026091516123863500_cit3","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.eururo.2024.04.010","article-title":"EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on\nprostate cancer. Part II\u25002024 update: Treatment of relapsing\nand metastatic prostate cancer","volume":"86","author":"Tilki","year":"2024","journal-title":"Eur. Urol."},{"issue":"10","key":"2026091516123863500_cit4","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/s41585-024-00875-x","article-title":"From biology to the\nclinic\u2500exploring liver metastasis in prostate\ncancer","volume":"21","author":"Ni","year":"2024","journal-title":"Nat. Rev. Urol."},{"issue":"2","key":"2026091516123863500_cit5","doi-asserted-by":"publisher","first-page":"101","DOI":"10.14744\/ijmb.2024.93585","article-title":"Unveiling the latest\ninsights into androgen receptors\nin prostate cancer","volume":"7","author":"Zakari","year":"2024","journal-title":"Int. J. Med. Biochem."},{"issue":"5","key":"2026091516123863500_cit6","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.37349\/etat.2024.00266","article-title":"Therapy resistance in\nprostate cancer: Mechanism, signaling and reversal strategies","volume":"5","author":"Thakur","year":"2024","journal-title":"Explor Target Antitumor Ther."},{"issue":"11","key":"2026091516123863500_cit7","doi-asserted-by":"publisher","first-page":"9","DOI":"10.22514\/jomh.2024.181","article-title":"Current state of\nprostate cancer treatment and future\nstrategies","volume":"20","author":"Pyo","year":"2024","journal-title":"J. Mens Health"},{"key":"2026091516123863500_cit8","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1007\/s12672-025-02198-8","article-title":"Advancements\nand limitations in traditional anti-cancer therapies: A comprehensive\nreview of surgery, chemotherapy, radiation therapy, and hormonal therapy","volume":"16","author":"Zafar","year":"2025","journal-title":"Discov Oncol."},{"issue":"1","key":"2026091516123863500_cit9","doi-asserted-by":"publisher","first-page":"201","DOI":"10.3390\/biomedicines12010201","article-title":"Anticancer drug discovery based on natural products:\nFrom computational approaches to clinical studies","volume":"12","author":"Chunarkar-Patil","year":"2024","journal-title":"Biomedicines"},{"issue":"7","key":"2026091516123863500_cit10","doi-asserted-by":"publisher","first-page":"3279","DOI":"10.3390\/ijms26073279","article-title":"Small-molecule\nmitotic inhibitors\nas anticancer agents: Discovery, classification, mechanisms of action,\nand clinical trials","volume":"26","author":"Salinas","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"2026091516123863500_cit11","doi-asserted-by":"publisher","DOI":"10.1002\/mog2.46","article-title":"Microtubule-targeting\nagents for cancer treatment: Seven binding sites and three strategies","volume":"2","author":"Wang","year":"2023","journal-title":"MedComm Oncol."},{"issue":"6","key":"2026091516123863500_cit12","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/s41585-025-01104-9","article-title":"20 years of\ntaxane therapy in prostate cancer\u2500the past, present and future","volume":"23","author":"Carceles-Cordon","year":"2026","journal-title":"Nat. Rev. Urol."},{"issue":"4","key":"2026091516123863500_cit13","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1097\/MOU.0000000000001296","article-title":"Toxicities of taxane-based\nchemotherapy in prostate cancer","volume":"35","author":"Matsukawa","year":"2025","journal-title":"Curr. Opin\nUrol."},{"issue":"3","key":"2026091516123863500_cit14","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3390\/biochem5030024","article-title":"Beyond\ndocetaxel: Targeting resistance pathways in prostate cancer treatment","volume":"5","author":"Adekiya","year":"2025","journal-title":"Biochem"},{"issue":"1","key":"2026091516123863500_cit15","doi-asserted-by":"publisher","first-page":"31","DOI":"10.5114\/wo.2024.138842","article-title":"Survival after docetaxel\nfor metastatic castration-resistant prostate cancer in a rural health\ncare setting","volume":"28","author":"Nieder","year":"2024","journal-title":"Contemp. Oncol."},{"issue":"20","key":"2026091516123863500_cit16","doi-asserted-by":"publisher","first-page":"2311","DOI":"10.1200\/JCO-25-00007","article-title":"Systemic\ntherapy in patients with metastatic\ncastration-resistant prostate cancer: ASCO guideline update","volume":"43","author":"Garje","year":"2025","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"2026091516123863500_cit17","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s40487-025-00412-9","article-title":"Treatment strategies\nin metastatic\ncastration-resistant prostate cancer: A narrative review of considerations\nin the post-ARTA, post-docetaxel setting","volume":"14","author":"Ng","year":"2026","journal-title":"Oncol.\nTher."},{"key":"2026091516123863500_cit18","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1038\/s41388-024-03059-4","article-title":"Targeting the glutamine metabolism to\nsuppress cell proliferation in mesenchymal docetaxel-resistant prostate\ncancer","volume":"43","author":"Beier","year":"2024","journal-title":"Oncogene"},{"issue":"15","key":"2026091516123863500_cit19","doi-asserted-by":"publisher","first-page":"7119","DOI":"10.3390\/ijms26157119","article-title":"Docetaxel\nresistance in breast cancer: Current insights and future directions","volume":"26","author":"Postigo-Corrales","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"2026091516123863500_cit20","doi-asserted-by":"publisher","first-page":"95","DOI":"10.7555\/JBR.37.20230248","article-title":"Drug resistance\nmechanisms in cancers: Execution of pro-survival strategies","volume":"38","author":"Dhanyamraju","year":"2024","journal-title":"J. Biomed. Res."},{"issue":"7","key":"2026091516123863500_cit21","doi-asserted-by":"publisher","first-page":"4382","DOI":"10.1007\/s12010-023-04595-7","article-title":"Chemoresistance\nmechanisms in non-small cell lung cancer\u2500opportunities\nfor drug repurposing","volume":"196","author":"Kaur","year":"2024","journal-title":"Appl. Biochem. Biotechnol."},{"issue":"8","key":"2026091516123863500_cit22","doi-asserted-by":"publisher","first-page":"574","DOI":"10.3390\/cells14080574","article-title":"Lysosomes and LAMPs\nas autophagy drivers of drug resistance in colorectal cancer","volume":"14","author":"Ivanova","year":"2025","journal-title":"Cells"},{"key":"2026091516123863500_cit23","doi-asserted-by":"publisher","first-page":"64","DOI":"10.20517\/cdr.2025.146","article-title":"MicroRNAs as key regulators of cancer\ndrug resistance: Insights and future directions in chemotherapy, targeted\ntherapy, radiotherapy, and immunotherapy","volume":"8","author":"Attathikhun","year":"2025","journal-title":"Cancer\nDrug Resist."},{"key":"2026091516123863500_cit24","doi-asserted-by":"publisher","first-page":"120643","DOI":"10.1016\/j.jep.2025.120643","article-title":"Targeting\nDNA damage: A natural product-based strategy for inhibiting cancer\nprogression","volume":"355","author":"Wang","year":"2026","journal-title":"J. Ethnopharmacol."},{"issue":"3","key":"2026091516123863500_cit25","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1039\/D4RA05089D","article-title":"Incredible\nuse of plant-derived bioactives as anticancer\nagents","volume":"15","author":"Kangra","year":"2025","journal-title":"RSC Adv."},{"issue":"24","key":"2026091516123863500_cit26","doi-asserted-by":"publisher","first-page":"4859","DOI":"10.2174\/0109298673325229240928040758","article-title":"Anticancer Drug Discovery from Natural Compounds Targeting\nPI3K\/AKT\/mTOR Signaling Pathway","volume":"32","author":"Figueiredo da Silva","year":"2025","journal-title":"Curr. Med.\nChem."},{"key":"2026091516123863500_cit27","doi-asserted-by":"publisher","first-page":"106957","DOI":"10.1016\/j.bioorg.2023.106957","article-title":"Discovery of plant-derived anti-tumor natural products: Potential\nleads for anti-tumor drug discovery","volume":"142","author":"Hui","year":"2024","journal-title":"Bioorg.\nChem."},{"issue":"6","key":"2026091516123863500_cit28","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1007\/s11101-024-09940-0","article-title":"Recent\nadvancements in natural compounds\nfor cancer therapy and prevention","volume":"23","author":"Pavithra","year":"2024","journal-title":"Phytochem.\nRev."},{"issue":"16","key":"2026091516123863500_cit29","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1055\/s-0042-115034","article-title":"Narciclasine\u2500an\nAmaryllidaceae alkaloid with potent antitumor and anti-inflammatory\nproperties","volume":"82","author":"Fu\u0308rst","year":"2016","journal-title":"Planta Med."},{"issue":"6","key":"2026091516123863500_cit30","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1021\/cr078198u","article-title":"Chemistry, biology,\nand medicinal potential of narciclasine\nand its congeners","volume":"108","author":"Kornienko","year":"2008","journal-title":"Chem. Rev."},{"issue":"1","key":"2026091516123863500_cit31","doi-asserted-by":"publisher","DOI":"10.29333\/ejgm\/14040","article-title":"Antitumor evaluation of Amaryllidaceae alkaloids on\ncancer cell lines: A literature review","volume":"21","author":"Martins de Paiva","year":"2024","journal-title":"Electron\nJ. Gen Med."},{"issue":"1","key":"2026091516123863500_cit32","doi-asserted-by":"publisher","first-page":"103","DOI":"10.20517\/cdr.2022.96","article-title":"Targeting hormone-resistant\nbreast cancer cells with docetaxel: A look inside the resistance","volume":"6","author":"Scherbakov","year":"2023","journal-title":"Cancer Drug Resist."},{"issue":"1","key":"2026091516123863500_cit33","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1021\/jacs.8b12123","article-title":"Enantioselective synthesis of isocarbostyril alkaloids\nand analogs using catalytic dearomative functionalization of benzene","volume":"141","author":"Bingham","year":"2019","journal-title":"J. Am. Chem. Soc."},{"issue":"3","key":"2026091516123863500_cit34","doi-asserted-by":"publisher","first-page":"3025","DOI":"10.1021\/acsomega.4c09867","article-title":"Antiparasitic activity of narciclasine and\nevaluation of its effects on plasma membrane and mitochondria of Trypanosoma\ncruzi","volume":"10","author":"Gomes","year":"2025","journal-title":"ACS Omega"},{"issue":"Suppl 2","key":"2026091516123863500_cit35","doi-asserted-by":"publisher","first-page":"W609","DOI":"10.1093\/nar\/gkq300","article-title":"PharmMapper server: A web server for potential\ndrug\ntarget identification using pharmacophore mapping approach","volume":"38","author":"Liu","year":"2010","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"2026091516123863500_cit36","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s13321-025-00973-x","article-title":"GNINA 1.3: The next\nincrement in molecular docking with deep learning","volume":"17","author":"McNutt","year":"2025","journal-title":"J. Cheminform."},{"issue":"1","key":"2026091516123863500_cit37","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1002\/pro.3943","article-title":"UCSF ChimeraX: Structure\nvisualization for\nresearchers, educators, and developers","volume":"30","author":"Pettersen","year":"2021","journal-title":"Protein\nSci."},{"issue":"5","key":"2026091516123863500_cit38","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1038\/nprot.2016.051","article-title":"Computational protein\u2013ligand docking and virtual\ndrug screening with the AutoDock suite","volume":"11","author":"Forli","year":"2016","journal-title":"Nat.\nProtoc."},{"key":"2026091516123863500_cit39","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","article-title":"GROMACS: High performance\nmolecular simulations through multi-level parallelism from laptops\nto supercomputers","volume":"1\u20132","author":"Abraham","year":"2015","journal-title":"SoftwareX"},{"issue":"11","key":"2026091516123863500_cit40","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1002\/jcc.21816","article-title":"SwissParam:\nA fast force field generation tool for small organic molecules","volume":"32","author":"Zoete","year":"2011","journal-title":"J. Comput. Chem."},{"issue":"1","key":"2026091516123863500_cit41","first-page":"57","article-title":"Combination effect\nof curcumin with docetaxel on the PI3K\/AKT\/mTOR\npathway to induce autophagy and apoptosis in esophageal squamous cell\ncarcinoma","volume":"13","author":"Deng","year":"2021","journal-title":"Am. J. Transl. Res."},{"issue":"8","key":"2026091516123863500_cit42","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.3390\/pharmaceutics13081195","article-title":"Inhibitors of the PI3K\/Akt\/mTOR pathway in\nprostate cancer chemoprevention and intervention","volume":"13","author":"Roudsari","year":"2021","journal-title":"Pharmaceutics"},{"issue":"15","key":"2026091516123863500_cit43","doi-asserted-by":"publisher","first-page":"12222","DOI":"10.3390\/ijms241512222","article-title":"Dysregulated signalling pathways\ndriving anticancer drug resistance","volume":"24","author":"Bou Antoun","year":"2023","journal-title":"Int. J.\nMol. Sci."},{"issue":"11","key":"2026091516123863500_cit44","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.4161\/cc.6.11.4278","article-title":"Cyclin B and cyclin A confer different substrate recognition\nproperties on CDK2","volume":"6","author":"Brown","year":"2007","journal-title":"Cell Cycle"},{"issue":"10","key":"2026091516123863500_cit45","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.3390\/biom11101444","article-title":"Stress relief techniques: p38 MAPK determines the balance\nof cell cycle and apoptosis pathways","volume":"11","author":"Whitaker","year":"2021","journal-title":"Biomolecules"},{"issue":"8","key":"2026091516123863500_cit46","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1038\/nsb0896-696","article-title":"Structural\nbasis of cyclin-dependent\nkinase activation by phosphorylation","volume":"3","author":"Russo","year":"1996","journal-title":"Nat. Struct.\nBiol."},{"issue":"6538","key":"2026091516123863500_cit47","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/376313a0","article-title":"Mechanism of CDK activation revealed by\nthe structure of a cyclinA-CDK2 complex","volume":"376","author":"Jeffrey","year":"1995","journal-title":"Nature"},{"issue":"6589","key":"2026091516123863500_cit48","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/382325a0","article-title":"Crystal structure of the p27Kip1\ncyclin-dependent-kinase\ninhibitor bound to the cyclin A-Cdk2 complex","volume":"382","author":"Russo","year":"1996","journal-title":"Nature"},{"issue":"5","key":"2026091516123863500_cit49","doi-asserted-by":"publisher","first-page":"9314","DOI":"10.3390\/ijms16059314","article-title":"Insights on structural characteristics and ligand-binding\nmechanisms of CDK2","volume":"16","author":"Li","year":"2015","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"2026091516123863500_cit50","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1016\/j.bpj.2015.07.003","article-title":"Conformational equilibrium of CDK\/cyclin complexes\nby molecular dynamics with excited normal modes","volume":"109","author":"Floquet","year":"2015","journal-title":"Biophys. J."},{"key":"2026091516123863500_cit51","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1146\/annurev.med.53.082901.103929","article-title":"Mechanisms\nof cancer drug resistance","volume":"53","author":"Gottesman","year":"2002","journal-title":"Annu. Rev. Med."},{"issue":"3","key":"2026091516123863500_cit52","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/nrd1984","article-title":"Targeting multidrug resistance in\ncancer","volume":"5","author":"Szaka\u0301cs","year":"2006","journal-title":"Nat. Rev. Drug Discovery"},{"key":"2026091516123863500_cit53","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1186\/s12885-016-2629-y","article-title":"S6Ks isoforms contribute to viability,\nmigration, docetaxel resistance and tumor formation of prostate cancer\ncells","volume":"16","author":"Amaral","year":"2016","journal-title":"BMC Cancer"},{"key":"2026091516123863500_cit54","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s12943-022-01524-w","article-title":"CDK6-PI3K signaling\naxis is an efficient target for attenuating ABCB1\/P-gp-mediated\nmulti-drug resistance (MDR) in cancer cells","volume":"21","author":"Zhang","year":"2022","journal-title":"Mol. Cancer"},{"issue":"6","key":"2026091516123863500_cit55","doi-asserted-by":"publisher","first-page":"893","DOI":"10.3390\/biom11060893","article-title":"Overview of evidence-based\nchemotherapy for oral cancer: Focus on drug resistance related to\nthe epithelial\u2013mesenchymal transition","volume":"11","author":"Sha","year":"2021","journal-title":"Biomolecules"},{"issue":"10","key":"2026091516123863500_cit56","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.3390\/biomedicines9101353","article-title":"Targeting\ndrug chemo-resistance in cancer using natural products","volume":"9","author":"Talib","year":"2021","journal-title":"Biomedicines"},{"issue":"11","key":"2026091516123863500_cit57","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.3390\/biom12111565","article-title":"Focusing on\nthe role\nof natural products in overcoming cancer drug resistance: An autophagy-based\nperspective","volume":"12","author":"Yao","year":"2022","journal-title":"Biomolecules"},{"issue":"3","key":"2026091516123863500_cit58","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1111\/ajco.13449","article-title":"Role and\nmechanism of autophagy-regulating factors\nin tumorigenesis and drug resistance","volume":"17","author":"Usman","year":"2021","journal-title":"Asia Pac\nJ. Clin Oncol."},{"issue":"2","key":"2026091516123863500_cit59","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1002\/med.21253","article-title":"Narciclasine as well as other Amaryllidaceae\nisocarbostyrils are promising GTP-ase targeting agents against brain\ncancers","volume":"33","author":"Van Goietsenoven","year":"2013","journal-title":"Med. Res. Rev."},{"issue":"11","key":"2026091516123863500_cit60","doi-asserted-by":"publisher","first-page":"4575","DOI":"10.1096\/fj.10-162263","article-title":"Targeting eEF1A with\nAmaryllidaceae isocarbostyrils as a strategy to combat melanomas","volume":"24","author":"Van Goietsenoven","year":"2010","journal-title":"FASEB J."},{"issue":"6","key":"2026091516123863500_cit61","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.12518","article-title":"Narciclasine induces\nautophagy-dependent apoptosis\nin triple-negative breast cancer cells by regulating the AMPK\u2013ULK1\naxis","volume":"51","author":"Cao","year":"2018","journal-title":"Cell Prolif."},{"issue":"1","key":"2026091516123863500_cit62","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0297203","article-title":"Bruceine D and Narclasine\ninhibit the proliferation of breast cancer\ncells and the prediction of potential drug targets","volume":"19","author":"Chen","year":"2024","journal-title":"PLoS One"},{"issue":"5","key":"2026091516123863500_cit63","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1007\/s00709-014-0619-y","article-title":"Inhibition\nof root growth by narciclasine is caused by DNA damage-induced cell\ncycle arrest in lettuce seedlings","volume":"251","author":"Hu","year":"2014","journal-title":"Protoplasma"},{"issue":"2","key":"2026091516123863500_cit64","doi-asserted-by":"publisher","first-page":"161","DOI":"10.2174\/0929867323666151118121124","article-title":"Apoptosis-inducing effects of Amaryllidaceae\nalkaloids","volume":"23","author":"Nair","year":"2016","journal-title":"Curr. Med. Chem."},{"issue":"5","key":"2026091516123863500_cit65","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer:\nThe next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"issue":"4","key":"2026091516123863500_cit66","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1089\/adt.2014.573","article-title":"Three-dimensional cell\nculture systems and their applications in drug discovery and cell-based\nbiosensors","volume":"12","author":"Edmondson","year":"2014","journal-title":"Assay Drug Dev. Technol."},{"issue":"1","key":"2026091516123863500_cit67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neo.2014.12.004","article-title":"Spherical cancer models in tumor\nbiology","volume":"17","author":"Weiswald","year":"2015","journal-title":"Neoplasia"},{"issue":"3","key":"2026091516123863500_cit68","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/nprot.2008.226","article-title":"Spheroid-based\ndrug screen: Considerations and practical approach","volume":"4","author":"Friedrich","year":"2009","journal-title":"Nat. Protoc."},{"issue":"1","key":"2026091516123863500_cit69","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.jbiotec.2010.01.012","article-title":"Multicellular tumor spheroids: An underestimated tool\nis catching up again","volume":"148","author":"Hirschhaeuser","year":"2010","journal-title":"J. Biotechnol."},{"issue":"3","key":"2026091516123863500_cit70","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/nrc2602","article-title":"Cell cycle, CDKs and cancer: A changing paradigm","volume":"9","author":"Malumbres","year":"2009","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"2026091516123863500_cit71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S1383-5742(98)00022-2","article-title":"Cyclin-dependent\nkinases at the G1-S transition of the mammalian cell cycle","volume":"436","author":"Hengstschla\u0308ger","year":"1999","journal-title":"Mutat. Res., Rev. Mutat. Res."},{"issue":"2","key":"2026091516123863500_cit72","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.drudis.2019.12.001","article-title":"Targeting CDK2 in cancer:\nChallenges and opportunities\nfor therapy","volume":"25","author":"Tadesse","year":"2020","journal-title":"Drug Discov. Today"},{"issue":"4","key":"2026091516123863500_cit73","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0005120","article-title":"Integrated\nfunctional, gene expression and genomic\nanalysis for the identification of cancer targets","volume":"4","author":"Iorns","year":"2009","journal-title":"PLoS One"},{"issue":"24","key":"2026091516123863500_cit74","doi-asserted-by":"publisher","first-page":"4589","DOI":"10.3390\/molecules24244589","article-title":"Identification of high-affinity\ninhibitors of cyclin-dependent\nkinase 2 towards anticancer therapy","volume":"24","author":"Mohammad","year":"2019","journal-title":"Molecules"},{"issue":"12","key":"2026091516123863500_cit75","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0050999","article-title":"Docetaxel-resistance\nin prostate cancer: Evaluating associated phenotypic changes and potential\nfor resistance transfer via exosomes","volume":"7","author":"Corcoran","year":"2012","journal-title":"PLoS One"},{"issue":"6","key":"2026091516123863500_cit76","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.3390\/cancers13061290","article-title":"Molecular profiling of docetaxel-resistant\nprostate cancer cells identifies multiple mechanisms of therapeutic\nresistance","volume":"13","author":"Lima","year":"2021","journal-title":"Cancers"}],"container-title":["ACS Omega"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acsomega.6c05272","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/acsodf\/article-pdf\/11\/36\/54245\/68243293\/acsomega.6c05272.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/acsodf\/article-pdf\/11\/36\/54245\/68243293\/acsomega.6c05272.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T20:12:47Z","timestamp":1789503167000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/acsodf\/article\/11\/36\/54245\/5409019\/Overcoming-Docetaxel-Resistance-in-Prostate-Cancer"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,2]]},"references-count":76,"journal-issue":{"issue":"36","published-online":{"date-parts":[[2026,9,2]]},"published-print":{"date-parts":[[2026,9,15]]}},"URL":"https:\/\/doi.org\/10.1021\/acsomega.6c05272","relation":{},"ISSN":["2470-1343"],"issn-type":[{"value":"2470-1343","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,2]]}}}